Radiosensitivity of various normal tissues is largely dependent on radiation-triggered signal transduction pathways. Radiation simultaneously initiates distinct signaling from both DNA damage and cell membrane. Specifically, DNA strand breaks initiate cell-cycle delay, strand-break repair or programmed cell death, whereas membrane-derived signaling through phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) enhances cell viability. Here, activation of cytosolic phospholipase A 2 (cPLA 2 ) and production of the lipid second-messenger lysophosphatidylcholine were identified as initial events (within 2 min) required for radiation-induced activation of Akt and ERK1/2 in vascular endothelial cells. Inhibition of cPLA 2 significantly enhanced radiation-induced cytotoxicity due to an increased number of multinucleated giant cells and cell cycle-independent accumulation of cyclin B1 within 24-48 h of irradiation. Delayed programmed cell death was detected at 72-96 h after treatment. Endothelial functions were also affected by inhibition of cPLA 2 during irradiation resulting in attenuated cell migration and tubule formation. The role of cPLA 2 in the regulation of radiation-induced activation of Akt and ERK1/2 and cell viability was confirmed using human umbilical vein endothelial cells transfected with shRNA for cPLA 2 a and cultured embryonic fibroblasts from cPLA 2 a À/À mice. In summary, an immediate radiation-induced cPLA 2 -dependent signaling was identified that regulates cell viability and, therefore, represents one of the key regulators of radioresistance of vascular endothelial cells.
The immediate molecular events that trigger the biological response to ionizing radiation are initiated by the hydrolysis of water. The resulting hydroxyl radicals interact with cellular components such as DNA resulting in DNA strand breaks and subsequent activation of well-described signal transduction pathways. In contrast, immediate signal transduction initiated at the cell membrane is less well characterized. For example, ceramide is generated in endothelial cells within minutes after exposure to 20 Gy radiation that later results in apoptosis. 1, 2 However, endothelial cell viability is not affected by low doses of radiation (2) (3) (4) (5) pointing to involvement of the activation of pro-survival phosphatidylinositol 3-kinase (PI3K)/Akt signaling. [3] [4] [5] [6] There is a growing number of reports demonstrating increased viability of vascular endothelial cells in response to low doses of ionizing radiation due to activation of prosurvival signaling pathways. [5] [6] [7] [8] [9] Biologically active lipids and proteins, such as phospholipases, lipid kinases, and phosphatases, which regulate the production of lipid second messengers, can initiate pro-survival signal transduction. 10, 11 For example, phospholipase A 2 (PLA 2 ) hydrolyzes phospholipids at the sn-2-acyl ester bond, generating free fatty acids and lysophospholipid second messengers. 12 The PLA 2 superfamily can be divided into 10 enzyme groups by gene sequences. On the basis of biological properties, the classification of PLA 2 can be simplified into three main types: the cytosolic (cPLA 2 ), the secretory (sPLA 2 ), and the intracellular Ca 2 þ -independent (iPLA 2 ). 12 In mammalian cells, the sn-2-position of phospholipids is enriched with arachidonic acid (AA). 13 On the other hand, the most abundant phospholipid in mammalian cell membranes is phosphatidylcholine. Therefore, in addition to the release of free AA, the activation of cPLA 2 increases production of lysophosphatidylcholine (LPC).
LPC functions as the second messenger in signal transduction pathways, that regulate a number of cellular responses. 12, 14 Recent publications suggest an important role of LPC in endothelial cell activation leading to increased vascular proliferation, migration, expression of adhesion molecules, and inflammation. LPC stimulated proliferation in endothelial cells by transactivating the vascular endothelial growth factor receptor 2 and activating Akt and extracellular signal-regulated kinase (ERK)1/2. 15 Increased levels of LPC are linked directly to cytokine and chemokine production in endothelial cells by activating mitogen-activated protein kinase (MAPK) and PI3K/Akt pathways, thus regulating the chemotaxis of particular leukocyte subpopulations during inflammation. 16 LPC also displays biphasic regulation of inflammatory factors in endothelial cells, causing activation of NF-kB at low concentrations and its inhibition at higher concentrations. 17 Pro-survival signal transduction activated by ionizing radiation within vascular endothelium includes PI3K/Akt (PI3K/Akt) and MAPK pathways. 4, 6, 7, 9, 18 These pathways determine cellular response and sensitivity to radiation by ultimately controlling cell metabolism, proliferation, and cell death. 7, 19 In the present study, we identified a sequence of molecular events in irradiated vascular endothelial cells, constituting an immediate pro-survival signaling pathway activated by ionizing radiation. This pathway involves activation of cPLA 2 followed by the increased production of LPC, transactivation of Flk-1 and phosphorylation of Akt and ERK1/ 2. This pathway can contribute to endothelial cell viability.
Results

Temporal
relationship of Akt and ERK1/2 phosphorylation and activation of cytosolic PLA 2 following 3 Gy radiation. We have previously reported radiation-induced phosphorylation of Akt in endothelial cells. 5, 6 Comparison of treated cells with a time-matched sham-irradiated control demonstrated that maximal phosphorylation of Akt, as well as ERK1/2, occurred at 3 min after irradiation with 3 Gy (Figures 1a and b) . Increased Akt phosphorylation at Thr 308 /Ser 473 was first detected at 2 min after exposure to 3 Gy radiation (1.8-fold increase over sham-irradiated control; Figure 1b (Figure 1d ). In comparison, pretreatment of cells with inhibitors of sPLA 2 or iPLA 2 showed less than 20% decrease in PLA 2 activation (Figure 1d ). These data suggest that the major PLA 2 subtype activated by low dose of ionizing radiation is the cytosolic isoform, cPLA 2 . To determine whether cPLA 2 participates in radiation-induced phosphorylation of ERK1/2 and Akt, HUVECs were pretreated with the inhibitors for cPLA 2 , sPLA 2 , or iPLA 2 , irradiated with 3 Gy and lyzed at 3 min after irradiation. Western blot analysis showed that inhibitors of cPLA 2 , but not the inhibitors of sPLA 2 or iPLA 2 , markedly decreased radiation-induced activation of Akt and ERK1/2, suggesting that cPLA 2 contributes to the radiationinduced activation of these kinases (Figures 1e and f) .
To verify the role of cPLA 2 , we studied radiation-induced phosphorylation of Akt and ERK1/2 in HUVECs that were transiently transfected with nonsilencing shRNA or shRNA for the predominant isoform of the enzyme cPLA 2 a, and mouse embryonic fibroblasts (MEFs) from knockout (KO) mice for cPLA 2 a (cPLA 2 a À/À ) and wild-type mice (cPLA 2 a þ / þ ).
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Transient transfection of HUVECs with cPLA 2 a-shRNA leads to an B70% decrease in cPLA 2 a protein level compared to nonsilencing shRNA (Figure 2a) . Irradiation of HUVECs transfected with nonsilencing shRNA resulted in time course of Akt and ERK1/2 phosphorylation similar to that observed in irradiated nontransfected HUVECs (Figures 2b and 1a) . A similar trend, but with less pronounced activation was observed in irradiated MEF cPLA2a þ / þ (Figure 2c ). Radiation-induced phosphorylation of Akt and ERK1/2 was completely abrogated in HUVECs transfected with cPLA 2 ashRNA (Figure 2b ) as well as in MEF cPLA2aÀ/À (Figure 2c ) resembling the effect of cPLA 2 a inhibitors (Figures 1e and f) . These genetic knockdown and KO models support the regulatory role of cPLA 2 and implicate involvement of its a-isoform in radiation-induced activation of pro-survival kinases Akt and ERK1/2.
Radiation-induced LPC production and effects of exogenously added LPC species. As the most abundant phospholipid in the mammalian cell membrane is phosphatidylcholine, radiation-induced activation of cPLA 2 could lead to the increased production of LPC. To determine whether 3 Gy radiation induces LPC production, we labeled HUVECs with 3 H-palmitic acid for 90 min and then treated with 3 Gy. Thin-layer chromatography (TLC) of extracted total lipids from the irradiated HUVECs revealed a statistically significant increase in LPC production of 1.6-fold compared to untreated cells (Figures 3a and b) . To determine whether this increase in LPC is involved in radiation-induced signal transduction, we compared HUVEC response to ionizing radiation to the response triggered by various exogenously added LPC species. Four different LPC species (up to 20 mM) led to a slight increase in cell proliferation (up to 20%; Figure 3c ). Following this observation, we studied the effect of LPC on the activation of pro-survival pathways. Four LPC species (10 mM) added to HUVECs resulted in ERK1/2 and Radiation-induced activation of Flk-1. As Flk-1 has recently been reported to be transactivated by LPC in HUVECs, 15 we studied activation of Flk-1 in radiationinduced signaling as a possible connection between increased production of LPC and phosphorylation of ERK1/ 2 and Akt. HUVECs were irradiated with 3 Gy, lyzed 3-30 min later and subjected to western blot analysis. Treatment with 10 ng/ml VEGF for 15 min was used as a positive control. In response to 3 Gy radiation, phosphorylation of Flk-1 at Tyr Involvement of cPLA 2 in radiation-induced cell death. To determine the role of cPLA 2 in the viability of irradiated endothelial cells, we used specific cPLA 2 inhibitors in a number of cell survival assays. Clonogenic survival analysis showed that each inhibitor produced a statistically significant decrease in viability of HUVECs compared to irradiation alone (Figure 5a ). This effect was specific for cPLA 2 were transiently transfected with nonsilencing shRNA or shRNA for cPLA 2 a, treated with 3 Gy radiation and lyzed 2-10 min after the beginning of irradiation. The western blot analysis for cPLA 2 a, phospho-Akt, phospho-ERK1/2, total Akt or ERK1/2, and actin is shown. (c) Embryonic fibroblasts from mice with wild-type cPLA 2 a (cPLA 2 a þ / þ ) and from cPLA 2 a KO mice (cPLA 2 a À/À ) were treated with 3 Gy and lyzed 2-10 min after the beginning of irradiation. The western blot for cPLA 2 a, phospho-Akt, phospho-ERK1/2, total Akt or ERK1/2, and actin is shown this enhanced cell death, we first analyzed the effect of cPLA 2 inhibition on cell-cycle regulation in irradiated endothelial cells. As expected, 20 radiation alone caused a significant increase in the percentage of cells in G 1 /G 0 phase that was concurrent with a decrease in S phase at 24-48 h (data not shown). Similar results were observed in irradiated cells pretreated with cPLA 2 inhibitors (data not shown). We next studied levels of cyclin B1, which regulates activity of Cdk1 and transition through the cell cycle. 21, 22 After 24-48 h of treatment, cyclin B1 was dramatically increased in the cells treated with cPLA 2 inhibitors and radiation, whereas cells treated with radiation alone showed a significant delay in cyclin B1 expression ( Figure 5e ). As we did not detect any significant differences in cell cycle between irradiated cells and cells treated with cPLA 2 inhibitors and radiation, the observed cyclin B1 accumulation was cell cycle independent that can be associated with mitotic catastrophe. [22] [23] [24] Thus, we determined the effect of cPLA 2 also detected in cells treated with radiation alone, but it was delayed and significantly less pronounced (Figure 5d ). The formation of multinucleated giant cells concurrent with cell cycle-independent accumulation of cyclin B1 implicates mitotic catastrophe occurring during the inhibition of cPLA 2 -dependent pro-survival signaling in irradiated endothelial cells.
In most cases, mitotic catastrophe evolves to cell death through apoptosis. 22, 23 To determine whether apoptosis occurred in irradiated HUVECs pretreated with cPLA 2 inhibitors, we studied Annexin V and propidium iodide (PI) staining as well as nuclear morphology using PI staining. In both assays, we did not detect an increase in programmed cell death at 24-48 h after treatment (Figures 5f-h) . However, when HUVECs were pretreated with cPLA 2 inhibitors prior to irradiation, number of Annexin V-positive cells increased by 2-to 3-fold at 72 h and by 7-to 11-fold at 96 h, compared to control cells (Figures 5f and g ). Moreover, PI staining showed a 30-40% increase in apoptotic nuclei at 72 h after treatment (Figure 5h) .
To verify the role of cPLA 2 in radiation-induced cell viability, we studied mitotic catastrophe and apoptosis in irradiated HUVECs transfected with nonsilencing shRNA or cPLA 2 a shRNA as well as in irradiated MEF cPLA2a þ / þ and MEF cPLA2aÀ/À . Trends similar to the effects of cPLA 2 inhibitors in irradiated HUVECs were observed in both genetic models ( Figure 6 ). In HUVECs transfected with cPLA 2 a shRNA, the mitotic catastrophe at 48 h after irradiation was significantly increased compared to sham-irradiated cells (60 versus 40%; Figures 6a and b) . This difference was sustained up to 96 h after radiation, whereas no statistically significant changes in mitotic catastrophe were observed in irradiated and shamirradiated HUVECs transfected with nonsilencing shRNA over the course of the study (Figure 6b ). In apoptotic experiments, 24, 48, or 72 h after irradiation, no significant change was observed in either cell type (Figure 6c ). However, 96 h after treatment, irradiated HUVECs transfected with cPLA 2 a shRNA but not with nonsilencing shRNA demonstrated modest but statistically significant increase in apoptosis, compared to sham-irradiated cells (60 versus 45%; Figure 6c ). In irradiated MEF cPLA2a þ / þ and MEF cPLA2aÀ/À , similar levels of increase in the amount of multinucleated/giant cells were observed at 24 and 48 h after treatment compared to sham-irradiated cells (60 versus 30%; Figure 6d) . At 72 h, this difference was sustained in irradiated MEF cPLA2a þ / þ , but not in MEF cPLA2aÀ/À (Figure 6d ). In the apoptotic study, 24 or 48 h after irradiation, no significant change was observed in either cell type (Figure 6e ). However, 72-96 h after treatment, irradiated MEF cPLA2aÀ/À demonstrated an increase in apoptosis up to fourfold, compared to sham-irradiated cells (80 versus 20%; Figure 6e ). In contrast, we observed no statistically significant increase in apoptosis in irradiated MEF cPLA2a þ / þ versus control cells (Figure 6e ).
Effects of cPLA 2 on endothelial functions in irradiated HUVECs. We investigated the role of cPLA 2 in HUVECs migration by using two approaches: endothelial cell migration through a filter and endothelial cell gash closure ( Figure 7) . In both assays, radiation alone or inhibition of cPLA 2 with AACOCF 3 alone resulted in a 15% decrease in HUVEC migration, which was not statistically significant (Figures 7a We also found that inhibition of cPLA 2 activity affected endothelial tubule formation in irradiated HUVECs. Untreated cells attached to matrigel when plated and formed capillarylike structures within 24 h following irradiation. Irradiated cells or cells treated with cPLA 2 inhibitors alone did not show significant difference in the number of capillary-like tubules compared to that of untreated cells (Figures 7d and e) . However, irradiation combined with cPLA 2 inhibition caused a pronounced decrease of threefold (30% of control) in the number of formed tubules (Figures 7d and e) .
Discussion
Many common and life-threatening human diseases, including atherosclerosis, diabetes, cancer, and aging, have free radical reactions as an underlying mechanism of injury. Free radicals and other reactive oxygen and nitrogen species (ROS/RNS) are generated endogenously. 25 Overproduction of ROS results in oxidative stress, a deleterious process that can be an important mediator of damage to cell structures and biological molecules. In contrast, beneficial effects of ROS occur at low/moderate concentrations and involve physiological roles in cellular responses, such as in the activation of signaling pathways. 7, 8, 25 ROS/RNS-dependent damage to vascular endothelium involving radiation-induced environmental stress and radiotherapy is widely studied. 26, 27 However, the role of activation of pro-survival signal transduction pathways regulating the increased viability of vascular endothelial cells in response to low doses of ionizing radiation is underestimated and understudied.
Immediate pro-survival signaling in irradiated vascular endothelial cells. Our previous studies have shown that ionizing radiation triggers pro-survival signaling pathways that are specific and responsible for the inherent radioresistance of vascular endothelium. [4] [5] [6] 28 However, the detailed mechanism of activation of these pathways is not known, especially immediate events. Here we demonstrated that 3 Gy of ionizing radiation induced phosphorylation of two pro-survival kinases Akt and ERK1/2 at 2 min with maximum occurring at 3 min after exposure. Rapid and transient activation of these kinases could involve interaction of radiation-triggered ROS with membrane lipids, signaling proteins, or DNA. 1, 29, 30 We were specifically interested in lipid-derived second messengers that are immediately mobilized following irradiation. One such signaling pathway involves PLA 2 . In irradiated HUVECs, we detected immediate activation of cytosolic PLA 2 . Moreover, radiationinduced phosphorylation of Akt and ERK1/2 was dependent on and occurred immediately after activation of cPLA 2 . Similar results were obtained using irradiated HUVECs transfected with shRNA for cPLA 2 a compared to nonsilencing shRNA and MEFs from wild-type and KO mice for cPLA 2 a, confirming a regulatory role of cPLA 2 in the activation of radiation-induced activation of ERK1/2 and Akt and suggesting that the a-isoform of cPLA 2 family is a principal enzyme responsible for this regulation.
Activation of cPLA 2 leads to the increased production of lysophospholipids, such as LPC. 12, 14, 31 This biologically active lipid functions as the second messenger in signal transduction pathways, that regulate vascular proliferation, migration, expression of adhesion molecules, and inflammation. [14] [15] [16] In our study of irradiated HUVECs, LPC production was increased by 1.6-fold compared to untreated cells. To test whether this is involved in transduction of radiation signal, we compared HUVEC responses to ionizing radiation to the responses caused by exogenously added LPC. Cellular survival and proliferation in response to LPC treatment are dependent on LPC concentration.
14 Up to 25 mM of LPC have been reported to increase proliferation of HUVECs, 15 whereas higher concentrations promoted cell death. 32 In our study, 10 mM of four different exogenous LPC species did not cause a statistically significant change in cell proliferation. In addition, 10 mM of various LPC species resulted in ERK1/2 and Akt phosphorylation similar to those observed in irradiated cells. This suggests that PLA 2 -dependent production of LPC could be the mediator of endothelial radioresistance. Similarly, Fujita et al. 15 have shown that 20 mM LPC activated the same pro-survival kinases leading to increased HUVEC proliferation. The study also demonstrated LPC-dependent transactivation of Flk-1 (VEGFR2/KDR-1) followed by activation of cSrc. Interestingly, radiation-induced Akt phosphorylation is inhibited by specific inhibitors of VEGFR2, PI3K/Akt, and cSrc. 3, 4, 6, 28, 33 The role of Flk-1 in the radiation response of vascular endothelium is widely studied, 28, 34 however, the molecular mechanism of its radiation-induced activation is unknown. Upon ligand binding, Flk-1 undergoes autophosphorylation and becomes activated. Major autophosphorylation sites of Flk-1 are located in the kinase domain (Tyr 951/996 ) and in the tyrosine kinase catalytic domain (Tyr 1054/1059 ). 35 Here, we demonstrated that ionizing radiation resulted in specific phosphorylation of Flk-1 at Tyr 951 that was specifically abrogated by inhibition of cytosolic PLA 2 ., but not Ca 2 þ -independent or secretory members of PLA 2 family. Taken together with the study of Fujita et al., 15 we speculate that in vascular endothelial cells radiation-induced production of LPC leads to transactivation of Flk-1.
cPLA 2 in viability and inherent radioresistance of irradiated cells. We also have shown that inhibition of cPLA 2 significantly enhanced radiation-induced cell death in endothelial cells. We characterized the mechanisms of this cell death and detected an increased number of multinucleated giant cells and cell cycleindependent accumulation of cyclin B1 within 24-48 h of irradiation. These features are characteristic of mitotic catastrophe. 36 Later, mitotic catastrophe led to a delayed programmed cell death, which was detected at 72-96 h after treatment. In addition to regulation of viability of endothelial cells, we demonstrated that cPLA 2 inhibition affected endothelial cell function, resulting in attenuated migration and tubule formation in irradiated HUVECs.
The role of cPLA 2 in pro-survival signaling, viability, and radioresistance of irradiated cells was also confirmed using genetic knockdown and KO models. However, although the shRNA approach using HUVECs resulted in effects very similar to those observed in irradiated HUVECs pretreated with chemical inhibitors of cPLA 2 , the effects in cPLA 2 KO MEFs were less pronounced. We anticipated an explanation for the difference in genetic manipulation of cPLA 2 (acutely decreased protein level in knockdown model versus KO model) that allows for compensation mechanisms when other isoforms of enzyme could take over the functions of knockedout member of the family.
There are great differences in human organ and tissue sensitivity for radiation-induced damage. 37, 38 Low doses of ionizing radiation (2-3 Gy) do not affect viability of vascular endothelial cells. Moreover, there are studies demonstrating that active cPLA 2 and its product LPC are necessary for viability and proliferation of endothelial cells. 15, 39 We determined immediate radiation-dependent activation of a prosurvival signaling pathway that regulates viability and function of vascular endothelium. Our studies indicate a sequence of molecular events in irradiated endothelial cells, constituting an immediate signaling pathway activated by ionizing radiation (Figure 8a ). Activation of cPLA 2 resulted in the production of LPC, transactivation of Flk-1, and subsequent phosphorylation of Akt and ERK1/2. Inhibition of this pathway at different levels 3, 5, 6, 28 enhanced radiation-induced cell death characterized by mitotic catastrophe followed by a delayed programmed cell death (Figure 8b ). We propose that cPLA 2 signaling mediates radiation-dependent pro-survival response in vascular endothelial cells and, therefore, could represent one key regulator of inherent endothelial radioresistance. These data establish a biological basis for development of radiation mitigators and protectors.
Materials and Methods Chemicals. Organic solvents and PLA 2 inhibitors (AACOCF 3 and MAFP, cytosolic cPLA 2 inhibitors; PACOCF 3 , Ca 2 þ -independent PLA 2 inhibitor; cyclic (2-naphthylAla-Leu-Ser-2-naphthylAla-Arg), secreted sPLA 2 -IIA inhibitor I) were purchased from EMD Biosciences (San Diego, CA, USA). Tridecanoyl LPC (13 : 0), palmitoyl LPC (16 : 0); stearoyl LPC (18 : 0); oleoyl LPC (18 : 1); arachidoyl LPC (20 : 0); phosphatidylcholine (PC); phosphatidic acid (PA); lysophosphatidic acid (LPA), and sphingomyelin (SM) were purchased from Avanti Polar Lipids (Alabaster, AL, USA). All other chemicals were purchased from Sigma (St. Louis, MO, USA).
Cell culture and treatment. Primary culture of HUVECs pooled from multiple donors was obtained from Cambrex (East Rutherford, NJ, USA) and was maintained in EBM-2 medium (Cambrex). Embryonic fibroblasts from cPLA 2 a À/À and cPLA 2 a þ / þ mice (MEF cPLA2aÀ/À and MEF cPLA2a þ / þ ) were kindly provided by Dr. JV Bonventre (Renal Unit, Brigham Women's Hospital, Harvard Medical School, Boston, MA, USA). MEFs were maintained in Dulbecco's modified Eagle's medium/F-12 (1/1) with 10% FBS and 1% penicillin/streptomycin (Life Technologies, Gaithersburg, MD, USA). Cells from passages 2-5 were used in this study. HUVECs were starved for 6 h before treatment in MCDB 131 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 0.2% BSA. For the irradiation of cells, Therapax DXT 300 X-ray machine (Pantak Inc., East Haven, CT, USA) delivering 2.04 Gy/min at 80 kVP or Mark I 137 Cs irradiator (JL Shepherd and Associates, San Fernando, CA, USA) delivering 1.84 Gy/min were used. Due to high sensitivity of HUVECs to temperature and pH, cells were carried to the irradiator and back to the incubator in gas/temperature-controlled chamber (5% CO 2 , 371). In experiments with PLA 2 inhibitors, cells were treated for 30 min prior to 3 Gy irradiation with either 70% EtOH (control) or 1 mM AACOCF 3 , 1 mM MAFP, 1 mM PACOCF 3 , and 100 nM sPLA 2 -IIA inhibitor I dissolved in 70% EtOH. In experiments with LPC, cells were treated with either 70% EtOH (control) or with different species of LPC (10-80 mM) dissolved in 70% EtOH.
shRNA silencing of cPLA 2 a. HUVECs were transiently transfected using the pGIPZ lentiviral plasmid vector (Open Biosystems, Huntsville, AL, USA). This bicistronic vector allows estimation of the level of transfection by the expression of shRNA of interest in the first cistron, while keeping a high level of expression from second cistron encoding GFP. The vector contained either nonsilencing shRNA or shRNA for human cPLA 2 a (forward strand: CCTTGTATTCTCACCCTGATT; reversed strand: AATCAGGGTGAGAATACAAGGT). Quality control of the vectors was performed by restriction enzyme digestion with Sal1. Once HUVECs reached 50% confluency, cells were transfected with 5 mg of shRNA plasmid DNA in serum-free medium. After 48 h of incubation, the medium was aspirated and cells were replenished with endothelial growth medium. Cells were then examined microscopically for TurboGFP expression to estimate the level of transfection and then subjected to further treatment.
Immunoblot analysis. After treatment, HUVECs or MEFs were harvested at the indicated times. Total protein extraction was performed using M-PER kit (Pierce, Rockford, IL, USA). Protein concentration was quantified using BCA Reagent (Pierce) . Protein extracts (40 mg) were subjected to western immunoblot analysis using antibodies for the detection of phospho-Akt , total Akt, ERK1/2, and Flk-1, and cyclin B1 (all from Cell Signaling Technologies, Danvers, MA, USA). Antibody to actin (Sigma) was used to evaluate protein loading in each lane. Immunoblots were developed using the Western Lightning Chemiluminescence Plus detection system (PerkinElmer, Wellesley, MA, USA) according to the manufacturer's protocol.
